Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU)
NYSEARCA: TBXU · Real-Time Price · USD
32.16
-0.94 (-2.84%)
Dec 5, 2025, 4:00 PM EST - Market closed
-2.84% (1D)
| Assets | $4.24M |
| Expense Ratio | 0.97% |
| PE Ratio | n/a |
| Shares Out | 125,001 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 1,900 |
| Open | 33.26 |
| Previous Close | 33.10 |
| Day's Range | 32.16 - 33.26 |
| 52-Week Low | 25.71 |
| 52-Week High | 38.89 |
| Beta | n/a |
| Holdings | 12 |
| Inception Date | Oct 1, 2025 |
About TBXU
Fund Home PageThe Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is an exchange-traded fund that mostly invests in health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry. TBXU was launched on Oct 1, 2025 and is issued by Direxion.
Asset Class Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol TBXU
ETF Provider Direxion
Index Tracked NYSE Biotechnology Top 5 Equal Weight Index
Top 10 Holdings
103.84% of assets| Name | Symbol | Weight |
|---|---|---|
| Dreyfus Govt Cash Man Ins | n/a | 17.97% |
| Goldman Finl Sq Trsry Inst 506 | n/a | 17.72% |
| Goldman Sachs Fin Gov 465 Institut | n/a | 11.01% |
| Regeneron Pharmaceuticals, Inc. | REGN | 9.76% |
| Dx D Biotech T 5 Bull 2x Etf Swap | n/a | 9.75% |
| Amgen Inc. | AMGN | 9.44% |
| Vertex Pharmaceuticals Incorporated | VRTX | 8.87% |
| Gilead Sciences, Inc. | GILD | 8.24% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 7.67% |
| Cash | n/a | 3.39% |
News
New FDA Director Could Sway Biotech ETFs
Biotech stocks could sway toward the upside with the appointment of a new director at the Federal Drug Administration's Center for Drug Evaluation and Research. Dr. Richard Pazdur will take the reigns...
Other symbols: LABU
21 days ago - ETF Trends
Trade the Titans: Direxion Debuts New Suite of Leveraged & Inverse ETFs
New York, United States, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Direxion, a leading provider of tactical ETFs, today announced the launch of the Direxion Titans Leveraged & Inverse ETFs, a new suite of fun...
2 months ago - GlobeNewsWire